CRWD
The upgrade that couldn’t save the tape
CrowdStrike just got a louder thumbs-up from UBS, which reiterated a Buy and boosted its price target to $235 from $198. Normally, that kind of move would give a stock a little caffeine shot. Today? Not so much. CRWD is sliding anyway as investors lean risk-off and rotate away from high-multiple growth names.
Why the stock is wobbling
Part of the move is just market plumbing. CrowdStrike recently began trading on a split-adjusted basis after its 4-for-1 stock split, and those transitions can invite some short-term weirdness while traders recalibrate. Add in a market that’s suddenly acting like it left its appetite for risk at home, and you’ve got a recipe for profit-taking.
The chart still looks pretty happy
Despite the pullback, CrowdStrike’s longer-term setup is still flexing:
- It’s trading well above its 20-day and 200-day moving averages
- The moving averages are stacked in the classic bullish order
- MACD is still positive, which means momentum hasn’t fully rolled over
So yes, the stock is slipping. But no, this does not look like a full-on trend tantrum. More like a crowded bus making a few people stand up and re-balance.
What investors should care about
The big question isn’t whether UBS likes the stock — it’s whether the market is willing to keep paying up for cybersecurity leaders when growth names are under pressure. CrowdStrike’s fundamentals haven’t suddenly gone missing, but the stock is extended, and when that happens, even good news can feel like a shrug.
Big picture: CrowdStrike still has Wall Street in its corner, but the market is reminding everyone that even premium names can get treated like they overslept on a risk-off morning.